drugset / Trial / NCT00360074
Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to determine whether a body weight adjusted dose of thyroxin is superior to treatment guided by laboratory results of thyroxin hormones in patients with central hypothyroidism. Moreover beneficial effects of triiodthyronine supplementation are investigated.
Timeline
- Start
- 2004-02
- Primary completion
- —
- Completion
- 2007-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Liothyronine | Small molecule | 0.16 ug/kg | — |
| Subject | Thyroxin | Unknown | 1 ug/kg | — |
| Subject | Thyroxin | Unknown | 1.44 ug/kg | — |
| Subject | Thyroxin | Unknown | 1.6 ug/kg | — |